Vaccines are safe and effective in protecting individuals and populations against infectious diseases. New vaccines are evaluated by a long-standing, rigorous, and transparent process through the US Food and Drug Administration and the Centers for Disease Control and Prevention (CDC), by which safety and efficacy data are reviewed before authorization and recommendation.

The American Academy of Pediatrics (AAP) recommends the following related to coronavirus disease 2019 (COVID-19) vaccine in children and adolescents:

  • The AAP recommends COVID-19 vaccination for all children and adolescents 12 years of age and older who do not have contraindications using a COVID-19 vaccine authorized for use for their age.

  • Any COVID-19 vaccine authorized through Emergency Use Authorization by the US Food and Drug Administration, recommended by the CDC, and appropriate by age and health status can be used for COVID-19 vaccination in children and adolescents.

  • Given the importance of routine vaccination and the need for rapid uptake of COVID-19 vaccines, the AAP supports coadministration of routine childhood and adolescent immunizations with COVID-19 vaccines (or vaccination in the days before or after) for children and adolescents who are behind on or due for immunizations (based on the CDC and AAP Recommended Child and Adolescent Immunization Schedule) and/or at increased risk from vaccine-preventable diseases.

Yvonne A. Maldonado, MD, FAAP, Chairperson

Sean T. O’Leary, MD, MPH, FAAP, Vice Chairperson

Ritu Banerjee, MD, PhD, FAAP

James D. Campbell, MD, MS, FAAP

Mary T. Caserta, MD, FAAP

Jeffrey S. Gerber, MD, PhD, FAAP

Athena P. Kourtis, MD, PhD, MPH, FAAP

Ruth Lynfield, MD, FAAP, Red Book Associate Editor

Flor M. Munoz, MD, MSc, FAAP

Dawn Nolt, MD, MPH, FAAP

Adam J. Ratner, MD, MPH, FAAP

Samir S. Shah, MD, MSCE, FAAP

William J. Steinbach, MD, FAAP

Kenneth M. Zangwill, MD, FAAP

Theoklis E. Zaoutis, MD, MSCE, FAAP

David W. Kimberlin, MD, FAAP, Red Book Editor

Elizabeth D. Barnett MD, FAAP, Red Book Associate Editor

Mark H. Sawyer, MD, FAAP, Red Book Associate Editor

Henry H. Bernstein, DO, MHCM, FAAP, Red Book Online Associate Editor

H. Cody Meissner, MD, FAAP, Visual Red Book Associate Editor

Amanda C. Cohn, MD, FAAP – Centers for Disease Control and Prevention

Karen M. Farizo, MD – US Food and Drug Administration

Natasha B. Halasa, MD, MPH, FAAP – Pediatric Infectious Diseases Society

David Kim, MD – US Department of Health and Human Services Office of Infectious Disease and HIV/AIDS Policy

Eduardo López Medina, MD, MSc – Sociedad Latinoamericana de Infectologia Pediatrica

Denee Moore, MD, FAAFP – American Academy of Family Physicians

Scot B. Moore, MD, FAAP – Committee on Practice Ambulatory Medicine

Lakshmi Panagiotakopoulos, MD, MPH, FAAP – Centers for Disease Control and Prevention

Laura Sauvé, MD, FCPS – Canadian Paediatric Society

Neil S. Silverman, MD – American College of Obstetricians and Gynecologists

Jeffrey R. Starke, MD, FAAP – American Thoracic Society

Kay M. Tomashek, MD, MPH, DTM – National Institutes of Health

Jennifer M. Frantz, MPH

This document is copyrighted and is property of the American Academy of Pediatrics and its Board of Directors. All authors have filed conflict of interest statements with the American Academy of Pediatrics. Any conflicts have been resolved through a process approved by the Board of Directors. The American Academy of Pediatrics has neither solicited nor accepted any commercial involvement in the development of the content of this publication.

Policy statements from the American Academy of Pediatrics benefit from expertise and resources of liaisons and internal (AAP) and external reviewers. However, policy statements from the American Academy of Pediatrics may not reflect the views of the liaisons or the organizations or government agencies that they represent.

The guidance in this statement does not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate.

All policy statements from the American Academy of Pediatrics automatically expire 5 years after publication unless reaffirmed, revised, or retired at or before that time.

FUNDING: No external funding.

     
  • AAP

    American Academy of Pediatrics

  •  
  • CDC

    Centers for Disease Control and Prevention

  •  
  • COVID-19

    coronavirus disease 2019

Competing Interests

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.